Journal of Foot and Ankle Surgery
Volume 49, Issue 1 , Pages 37-42, January 2010

Moje First Metatarsophalangeal Replacement—A Case Series with Functional Outcomes Using the AOFAS-HMI Score

  • Mark Brewster, MRCS

      Affiliations

    • Orthopaedic Specialist Registrar, Heart of England NHS Trust, West Midlands, UK
    • Corresponding Author InformationAddress correspondence to: Mark Brewster MRCS, Orthopaedic Specialist Registrar, Heart of England NHS Trust, 8 Four Oaks Common Road, Sutton Coldfield, West Midlands, B744NJ, UK.
  • ,
  • John McArthur, MRCS

      Affiliations

    • Orthopaedic Registrar, University Hospitals Coventry and Warwickshire, Coventry, UK
  • ,
  • Cyril Mauffrey, MRCS

      Affiliations

    • Orthopaedic Specialist Registrar, Heart of England NHS Trust, Solihull, UK
  • ,
  • Andrew Charles Lewis, MRCS

      Affiliations

    • Orthopaedic Specialist Registrar, Heart of England NHS Trust, Solihull, UK
  • ,
  • Peter Hull, MRCS

      Affiliations

    • Orthopaedic Registrar, University Hospitals Coventry and Warwickshire, Coventry, UK
  • ,
  • James Ramos, LMS, MD, PhD, FRCS (Trauma & Orth)

      Affiliations

    • Consultant Foot and Ankle Surgeon, Foot & Ankle Specialist Service, Heart of England NHS Trust, West Midlands, UK

Abstract 

We report the functional results of a case series of Moje first metatarsophalangeal total joint replacements carried out between February 2001 and November 2006. All patients who underwent Moje arthroplasty under the care of a single surgeon were included; outcome scores and complications were recorded annually. A total of 32 joints in 29 consecutive patients were followed for a mean duration of 34 (range 6 to 74) months, and the mean patient age at the time of operation was 56 (range 38 to 79) years. Hallux rigidus was the primary diagnosis in 28 (87.5%) of the cases. The mean American Orthopaedic Foot & Ankle Society Hallux-Metatarsophalangeal-Interphalangeal score at final follow-up was 74/100 (range 9 to 100), with 13 (40.63%) joints rated good to excellent. Two (6.25%) joints were revised to arthrodesis at a mean of 52 (range 41 to 63) months following the arthroplasty procedure, and the overall prevalence of postoperative complications was 6 (18.75%). Based on these results, we concluded that first MTPJ total joint replacement with the Moje device remains promising, but still has room for improvement before the results match those obtained with larger joint (knee, hip) arthroplasty.

Level of Clinical Evidence: 4

Keywords: arthritis, arthrodesis, endoprosthesis, great toe, metatarsal, total joint replacement, surgery

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 25.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Financial Disclosure: None reported.

 Conflict of Interest: None reported.

PII: S1067-2516(09)00353-6

doi:10.1053/j.jfas.2009.08.009

Journal of Foot and Ankle Surgery
Volume 49, Issue 1 , Pages 37-42, January 2010